Camlin Fine Sciences · NSE: CAMLINFINE · BSE: 532834
Q4 FY26 results · Jan–Mar 2026
Camlin Fine Sciences reported revenue from operations of ₹424.81 crore (down 2.9% from Q4 FY25) and net profit of ₹86.28 crore (up 78333.9% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 424.81 | 437.46 | −2.9% | 457.20 | −7.1% |
| Other income | 23.91 | 9.59 | +149.3% | 2.94 | +714.6% |
| Total income | 448.72 | 447.06 | +0.4% | 460.13 | −2.5% |
| Profit before share of associates & JVs and tax | (6.65) | 28.91 | Turned loss | (27.60) | Loss narrowed |
| Share of profit/(loss) of associates & JVs | 1.38 | 1.79 | (0.25) | ||
| Net profit for the period | 86.28 | 0.11 | 784x | (37.10) | Turned profit |
| Attributable to shareholders of the company | 88.20 | (0.72) | Turned profit | (36.23) | Turned profit |
| EPS, basic (₹) | 4.59 | (0.04) | Turned profit | (1.91) | Turned profit |
| Net margin (%) | 20.3 | 0.0 | -8.1 |
This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 183.52 | 272.60 | −32.7% | 218.92 | −16.2% |
| Other income | 15.30 | 8.94 | +71.2% | 5.77 | +165.3% |
| Total income | 198.82 | 281.53 | −29.4% | 224.69 | −11.5% |
| Profit before tax | (16.64) | 11.90 | Turned loss | (17.27) | Loss narrowed |
| Net profit for the period | (5.65) | 15.62 | Turned loss | (13.00) | Loss narrowed |
| EPS, basic (₹) | (0.29) | 0.86 | Turned loss | (0.69) | Loss narrowed |
| Net margin (%) | -3.1 | 5.7 | -5.9 |
Consolidated
- Filed with BSE
- 26 May 2026, 18:59 IST
- Board meeting
- 26 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 26 May 2026, 18:59 IST
- Board meeting
- 26 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE